Biodexa Pharmaceuticals Plc
Clinical-stage biopharma developing treatments for rare diseases, diabetes, and cancer.
BDRX | US
Overview
Corporate Details
- ISIN(s):
- GB00BNGF1L75 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 1 CASPIAN POINT, CARDIFF
- Website:
- https://www.biodexapharma.com/
- Sector:
- Manufacturing
Description
Biodexa Pharmaceuticals Plc is a clinical-stage biopharmaceutical company developing a pipeline of treatments for diseases with high unmet medical needs. The company's lead candidate, eRapa™, is a proprietary oral formulation of rapamycin being advanced for a Phase 3 trial in familial adenomatous polyposis (FAP), a rare genetic disorder that leads to colorectal cancer. The eRapa™ formulation is designed using nanotechnology to improve the drug's bioavailability and provide more consistent pharmacokinetics. The development pipeline also includes Tolimidone, a potential first-in-class lyn kinase inhibitor for the treatment of type 1 diabetes, and other programs targeting primary and metastatic brain cancers.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Biodexa Pharmaceuticals Plc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Biodexa Pharmaceuticals Plc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Biodexa Pharmaceuticals Plc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
